Product Description
The biolimus-eluting coronary stent contains a stainless steel platform on which an abluminally coated polylactic acid (PLA) biodegradable polymer is placed that eludes biolimus-A9. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01137019)
Mechanisms of Action: Immunosuppressive
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Colombia | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: Biosensors Europe
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Coronary Artery Disease|Myocardial Ischemia|ST Elevation Myocardial Infarction|Dyslipidemia|Stroke|Inflammation|Myocardial Infarction|Thrombosis|Hypertension|Angina, Stable|Acute Coronary Syndrome
Phase 3: Myocardial Ischemia|Coronary Artery Disease|Coronary Disease
Phase 2: Coronary Artery Disease|Coronary Thrombosis|ST Elevation Myocardial Infarction|Myocardial Ischemia
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
2024-02-008-H01 | N/A |
Not yet recruiting |
Coronary Disease |
2027-05-23 |
|
LEADERS FREE IV (RCT) | N/A |
Recruiting |
Angina, Unstable|Coronary Artery Disease|Angina, Stable|Myocardial Ischemia|Angina Pectoris|Acute Coronary Syndrome |
2026-08-01 |
|
ChiCTR2000041438 | N/A |
Recruiting |
Coronary Disease |
2025-12-31 |
|
JW-PM-DCB-2024 | N/A |
Not yet recruiting |
Coronary Artery Disease|Myocardial Ischemia |
2025-12-30 |
|
REFORM | N/A |
Unknown status |
Coronary Artery Disease|Coronary Restenosis|Coronary Stenosis |
2023-04-01 |
|
SORTOUTXI | N/A |
Active, not recruiting |
Coronary Artery Disease |
2023-03-19 |
|
JW-BA9-ISR-202001 | N/A |
Active, not recruiting |
Coronary Artery Disease |
2023-01-18 |
|
2006-7041-83/hah | N/A |
Not yet recruiting |
Osteoarthritis, Knee|Total Knee Arthroplasty |
2022-10-31 |
|
Brave | N/A |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2021-02-20 |
|
BioFreedomQCA | N/A |
Unknown status |
Coronary Artery Disease|Myocardial Infarction |
2019-09-30 |
|
CHOICE | N/A |
Terminated |
Myocardial Ischemia|Coronary Artery Disease |
2017-12-05 |
|
BEAUTY-II | P4 |
Unknown status |
Stroke|Acute Coronary Syndrome|Myocardial Infarction |
2017-08-01 |
|
TRICVD1311 | P3 |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2016-07-01 |
|
OPINION | P3 |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2016-07-01 |
|
EuroCTO | N/A |
Completed |
Coronary Occlusion|Angina, Stable|Dyspnea |
2016-05-01 |
|
NEXT | P4 |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2015-10-01 |
|
BESS | P4 |
Unknown status |
Coronary Artery Disease|Myocardial Ischemia |
2015-07-01 |
|
NCT01502904 | P4 |
Completed |
Acute Coronary Syndrome|Angina, Stable|Hypertension|Dyslipidemia |
2015-05-01 |
|
OCT SORT-OUT | N/A |
Active, not recruiting |
Coronary Artery Disease|Angina Pectoris|Myocardial Infarction |
2015-04-01 |
|
OPTIMA | P3 |
Unknown status |
Coronary Artery Disease|Myocardial Ischemia |
2014-12-01 |
|
EVERBIOII | P4 |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2013-12-01 |
|
CTO | P4 |
Unknown status |
Coronary Artery Disease|Myocardial Ischemia |
2013-10-01 |
|
MUW-0001 | P4 |
Completed |
Thrombosis|Inflammation |
2013-08-01 |
|
LONG-DES-V | P4 |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2013-05-01 |
|
SO VI | N/A |
Completed |
Myocardial Ischemia|Angina Pectoris|Coronary Artery Disease |
2012-07-01 |